Chief Medical & Scientific Officer Richard Kuntz to retire April 29, 2022

Medtronic plc

Richard Kuntz notified Medtronic on Dec 14, 2021 of retirement effective April 29, 2022.
Kuntz served as SVP and Chief Medical & Scientific Officer and on executive committee since 2005.
He leaves after over 15-year tenure at Medtronic and 40-year career as interventional cardiologist.
Filing does not name a successor or interim replacement for the role.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Richard Kuntz

Senior Vice President and Chief Medical and Scientific Officer

MDT · Medtronic plc

Effective: 2022-04-29
Filed: December 16, 2021, 6:59 PM ET

On December 14, 2021, Richard Kuntz, M.D. notified Medtronic plc (the “Company”) that he had decided to retire as Senior Vice President and Chief Medical and Scientific Officer of the Company, effective as of April 29, 2022.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Richard Kuntz retired as Senior Vice President and Chief Medical and Scientific Officer at Medtronic plc.

Action: retired
Role: Senior Vice President and Chief Medical and Scientific Officer

Exact text from the filing

On December 14, 2021, Richard Kuntz, M.D. notified Medtronic plc (the “Company”) that he had decided to retire as Senior Vice President and Chief Medical and Scientific Officer of the Company, effective as of April 29, 2022.

View on SEC.gov

Medtronic plc filing history →

Source: SEC EDGAR

accession 0001613103-21-000070

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.